Department of Community Medicine, School of Medicine, Medicinal & Natural Products Chemistry Research Centre, Shiraz University of Medical Sciences, Shiraz, Iran.
Clin Microbiol Infect. 2012 Nov;18(11):1081-8. doi: 10.1111/1469-0691.12021. Epub 2012 Oct 3.
Thanks to improved health standards in Iran over the past three decades, we have witnessed a shift in the causes of death in Iran from infectious causes to non-communicable diseases-mainly cardiovascular disorders, cancers, and road traffic injuries. The incidence and prevalence of many infectious diseases, such as many parasitic infections, have fallen significantly; there have been no reported cases of dracunculiasis in Iran since the mid-1970s. Great strides have also been made towards the elimination of schistosomiasis in Iran. However, we still have some problems with cutaneous leishmaniasis, hepatitis C, human immunodeficiency virus, tuberculosis, infections among immunocompromised hosts, hospital-acquired infections, and antibiotic-resistant bacterial strains. We need to emphasize improvements in sanitation, good clinical practice, and education about the rational administration of antibiotics.
由于伊朗在过去三十年中健康标准的提高，我们见证了伊朗的死亡原因从传染病向非传染性疾病转变——主要是心血管疾病、癌症和道路交通伤害。许多传染病的发病率和患病率显著下降；自 20 世纪 70 年代中期以来，伊朗已无麦地那龙线虫病报告病例。伊朗在消灭血吸虫病方面也取得了重大进展。然而，我们仍然面临一些皮肤利什曼病、丙型肝炎、人类免疫缺陷病毒、结核病、免疫功能低下宿主感染、医院获得性感染和抗生素耐药菌的问题。我们需要强调改善卫生、良好的临床实践以及合理使用抗生素的教育。
